These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20160715)

  • 21. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
    Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
    Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.
    Willkens RF; Leonard PA; Clegg DO; Tolman KG; Ward JR; Marks CR; Greene ML; Roth GJ; Jackson CG; Cannon GW
    Ann Rheum Dis; 1990 Aug; 49(8):591-3. PubMed ID: 2396863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate and the liver.
    Tolman KG; Clegg DO; Lee RG; Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():29-34. PubMed ID: 3831362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
    Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM
    Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity.
    Leonard PA; Clegg DO; Carson CC; Cannon GW; Egger MJ; Ward JR
    Clin Rheumatol; 1987 Dec; 6(4):575-82. PubMed ID: 3449308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
    Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
    [No Abstract]   [Full Text] [Related]  

  • 29. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis.
    Kremer JM; Furst DE; Weinblatt ME; Blotner SD
    J Rheumatol; 1996 Mar; 23(3):459-61. PubMed ID: 8832983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
    Temtem TA; Vickers M; Whitworth J
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: methotrexate in gastroenterology--dangerous villain or simply misunderstood?
    Tang H; Neuberger J
    Aliment Pharmacol Ther; 1996 Dec; 10(6):851-8. PubMed ID: 8971280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of methotrexate for treatment of inflammatory bowel disease in clinical practice.
    Saibeni S; Bollani S; Losco A; Michielan A; Sostegni R; Devani M; Lupinacci G; Pirola L; Cucino C; Meucci G; Basilisco G; D'Incà R; Bruno S
    Dig Liver Dis; 2012 Feb; 44(2):123-7. PubMed ID: 22051323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
    Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
    Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.
    Varatharajan N; Lim IG; Anandacoomarasamy A; Russo R; Byth K; Spencer DG; Manolios N; Howe GB
    Intern Med J; 2009 Apr; 39(4):228-36. PubMed ID: 19402861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.